While a US FDA advisory panel narrowly voted against approval of Trevena Inc.'s intravenous opioid Olinvo (oliceridine) on Oct. 11, several members indicated that the drug could get their support with more data.
The Anesthetic and Analgesic Drug Products Advisory Committee voted 8-7 against recommending approval of the drug for acute pain in...